Overview
Nathan Handley is an Integrative Medicine provider practicing medicine in Villanova, Pennsylvania.
Dr. Handley is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, and Clear Cell Sarcoma.
Dr. Handley is board certified in Medical Oncology and Internal Medicine. He is actively involved in clinical research, co-authoring 34 peer reviewed articles. Dr. Handley is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
789 East Lancaster Avenue, Suite 110, Villanova, PA 19085
925 Chestnut Street, Suite 120, Philadelphia, PA 19107
Additional Areas of Focus
Dr. Handley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Pennsylvania
Jakub Svoboda is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Svoboda is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Abramson Cancer Center Perelman 2nd Floor West
Corey Langer is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Langer is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Langer is board certified in Medical Oncology, 1987, Hematology, 1986, and Internal Medicine, 1984. Dr. Langer is currently accepting new patients.
Jefferson Medical Oncology-Honickman Center
Pierluigi Porcu is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Porcu is highly rated in 25 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Nathan R. Handley
How do I make an appointment with Dr. Nathan R. Handley?
You can book an appointment with Dr. Nathan R. Handley by calling their office at 215-955-2221. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nathan R. Handley a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nathan R. Handley is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nathan R. Handley specialize in?
While Dr. Nathan R. Handley is a Oncology, they have specific expertise in Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Familial Wilms Tumor 2. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Nathan R. Handley participate in research or clinical trials?
Yes. Dr. Nathan R. Handley has published 34 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Nathan R. Handley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nathan R. Handley accept my insurance?
Dr. Nathan R. Handley accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-955-2221 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Handley isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Handley isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Handley isAdvanced. Learn about Familial Wilms Tumor 2.
- Prostate CancerDr. Handley isAdvanced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Handley isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorDr. Handley isAdvanced. Learn about Wilms Tumor.
- Experienced
- Adult Soft Tissue SarcomaDr. Handley isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Handley isExperienced. Learn about Bladder Cancer.
- Familial Prostate CancerDr. Handley isExperienced. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Handley isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Handley isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
- Penile CancerDr. Handley isExperienced. Learn about Penile Cancer.